Sorry, you need to enable JavaScript to visit this website.

Competition/Antitrust

Indian appellate tribunal confirms abuse of dominance by Google

Submitted by content_author on Wed, 03/29/2023 - 23:35

On 20 October 2022, the Competition Commission of India (CCI) had imposed a penalty of INR 1,337.76 crore (~USD 162 million) on Google for abusing its dominant position in multiple markets by mandating original equipment manufacturers (OEM) to pre-install Google’s suite of applications (GMS Suite) as a pre-requisite for accessing the Android Operating System (OS).

Indian Competition Authority releases its market study findings on the Taxi and Cab aggregator industry

Submitted by indigoadmin on Fri, 09/16/2022 - 16:13

On 9 September 2022, the Competition Commission of India (Commission) released its findings pursuant to a market study on the taxi and cab aggregator industry in its report with special reference to surge pricing (Market Study).

CCI releases its market study findings on the pharmaceutical sector in India

Submitted by indigoadmin on Tue, 11/23/2021 - 17:39

Within close to a year of initiation of its market study into the pharmaceutical sector, on 18 November 2021, the Competition Commission of India (CCI) released its findings in its report titled ‘Market Study on the Pharmaceutical Sector in India: Key Findings and Observations.

CCI enters memorandum on Co-Operation with Japanese Antitrust Regulator

Submitted by indigoadmin on Mon, 07/12/2021 - 17:46

On 8 July 2021, the Union Cabinet of India approved the Memorandum on Co-operation (MoC) between the Competition Commission of India (CCI) and Japan’s competition agency, the Japan Fair Trade Commission (JFTC). The MoC aims to promote and strengthen co-operation in matters of competition law and policy.

CCI dismisses allegation of bid-rigging against Romsons and Essity

Submitted by indigoadmin on Wed, 01/20/2021 - 18:06

The Competition Commission of India (CCI) took suo moto cognisance of alleged cartelisation between Romsons Scientific & Surgical Industrial Private Limited (Romsons / OP-1) and BSN Medical Private Limited (now known as Essity India Private Limited) (BSN / Essity / OP-2; along with Romsons, referred to as the OPs) in an open tender for surgical tapes invited by All India Institute of Medical Sciences (AIIMS).